Transcranial Direct Current Stimulation for Post-stroke Fatigue

Description

The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.

Conditions

Fatigue, Stroke Rehabilitaion

Talk to us

Study Overview

On this page

Study Details

Study overview

The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.

Home-based Post-stroke Fatigue Treatment Using Transcranial Direct Current Stimulation (tDCS)

Transcranial Direct Current Stimulation for Post-stroke Fatigue

Condition
Fatigue
Intervention / Treatment

-

Contacts and Locations

New York

Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or female patients aged \>18 years
  • * Greater than 3 months from first hemorrhagic or ischemic stroke (subacute to chronic), confirmed through neuroimaging (CT or MRI).
  • * Fatigue severity score average \>4 (severe fatigue)
  • * Willingness to remain stable on pharmacologic therapy through the duration of the study.
  • * Availability of a caregiver, family member, or friend to be present during the administration of the tDCS intervention.
  • * Metal in the head (except mouth) or implanted cranial or thoracic devices (i.e. pacemaker, DBS stimulator)
  • * History of seizure
  • * History of moderate to severe traumatic brain injury
  • * A score of 10 or more on the PHQ-9 or GAD-7 scale, suggestive of moderate to severe depression/anxiety.
  • * A score of less than 21 on the MoCA suggesting major neurocognitive disorder.
  • * Signs of skin rash, infection, or laceration in the supraorbital region where the tDCS will be applied.
  • * Inability to provide informed consent
  • * Other major neurological, medical, or psychiatric illnesses that could confound results in the opinion of the site investigator.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Weill Medical College of Cornell University,

Joan M Stilling, MD, MS, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

2025-12